UTHR
UNITED THERAPEUTICS
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: UTHR
- PE Ratio
As at Aug 21, 2026, the UTHR stock has a PE ratio of 16.97. This is based on the current EPS of $30.24 and the stock price of $513.12 per share. The current PE ratio is comparable to the past 4-quarter average.
UTHR PE ratio history
The mean historical PE ratio of UNITED THERAPEUTICS over the last ten years is 12.96. The current 16.97 PE ratio is 31% above the historical average. Over the past ten years, UTHR's PE ratio was at its highest in the Dec 2021 quarter at 20.38, with a price of $216.08 and an EPS of $10.6. The Jun 2018 quarter recorded the bottom point at 6.85, with a price of $113.15 and an EPS of $16.53.
UNITED THERAPEUTICS PE ratio by year
Maximum annual increase: 254.1% in 2013
Maximum annual decrease: -62.93% in 2011
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 16.17 | 21.21% | $487.25 | $30.13 |
| 2024 | 13.34 | 27.66% | $352.84 | $26.44 |
| 2023 | 10.45 | -39.94% | $219.89 | $21.04 |
| 2022 | 17.4 | -14.62% | $278.09 | $15.98 |
| 2021 | 20.38 | 56.41% | $216.08 | $10.6 |
| 2020 | 13.03 | N/A | $151.79 | $11.65 |
| 2019 | N/A | N/A | $88.08 | -$2.39 |
| 2018 | 8.04 | -48.36% | $108.9 | $13.54 |
| 2017 | 15.57 | 76.93% | $147.95 | $9.5 |
| 2016 | 8.8 | -20.36% | $143.43 | $16.29 |
| 2015 | 11.05 | -39.75% | $156.61 | $14.17 |
| 2014 | 18.34 | -43.4% | $129.49 | $7.06 |
| 2013 | 32.4 | 254.1% | $113.08 | $3.49 |
| 2012 | 9.15 | -26.21% | $53.42 | $5.84 |
| 2011 | 12.4 | -62.93% | $47.25 | $3.81 |
UNITED THERAPEUTICS PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 17.92 | -11.51% | $541.83 | $30.24 |
| Mar 2026 | 20.25 | 25.23% | $592.98 | $29.28 |
| Dec 2025 | 16.17 | 9.85% | $487.25 | $30.13 |
| Sep 2025 | 14.72 | 41.81% | $419.21 | $28.48 |
| Jun 2025 | 10.38 | -8.79% | $287.35 | $27.68 |
| Mar 2025 | 11.38 | -14.69% | $308.27 | $27.08 |
| Dec 2024 | 13.34 | -9.5% | $352.84 | $26.44 |
| Sep 2024 | 14.74 | 6.81% | $358.35 | $24.31 |
| Jun 2024 | 13.8 | 34.37% | $318.55 | $23.09 |
| Mar 2024 | 10.27 | -1.72% | $229.72 | $22.36 |
| Dec 2023 | 10.45 | -10.84% | $219.89 | $21.04 |
| Sep 2023 | 11.72 | 0% | $225.87 | $19.28 |
| Jun 2023 | 11.72 | -17% | $220.75 | $18.83 |
| Mar 2023 | 14.12 | -18.85% | $223.96 | $15.86 |
| Dec 2022 | 17.4 | 29.75% | $278.09 | $15.98 |
UTHR Price vs fair value
UTHR average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, UTHR's PE ratio is greater than its 3, 5 and 10-year historical averages.
PE comparison
With a P/E of 16.97, UTHR is above the industry average but below the Healthcare sector and its peers average. Compared to its Healthcare sector average of 24.52, UNITED THERAPEUTICS's P/E is 31% lower.
UTHR PE vs peers
Frequently asked questions
What is UNITED THERAPEUTICS's PE ratio?
As of Aug 21, 2026, UTHR stock has a price to earnings ratio of 16.97.
What is the 3-year average PE ratio for UNITED THERAPEUTICS (UTHR)?
The 3-year average PE ratio for UTHR stock is 13.76.
What is the 5-year average PE ratio for UNITED THERAPEUTICS (UTHR)?
The 5-year average PE ratio for UTHR stock is 14.43.
What is the highest PE ratio for UTHR?
Over the last ten years, the quarterly PE ratio reached a historic high of 20.38 in the Dec 2021 quarter.
How does the current PE ratio for UTHR compare to its historical average?
UTHR's current price to earnings ratio is 31% above its 10-year historical average.
How is UTHR's PE ratio calculated (UNITED THERAPEUTICS PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Aug 21, 2026), UNITED THERAPEUTICS's stock price is $513.12. The earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $30.24. Therefore, UNITED THERAPEUTICS's P/E ratio for today is 16.97. PE RATIO(16.97) = STOCK PRICE($513.12) / TTM EPS($30.24)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.